Nuzenio

Vistagen

Vistagen news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 14:39:45 GMTVistagen reports exploratory Phase II miss for social anxiety drug candidate - AllSci
Fri, 07 Aug 2026 12:22:37 GMTVistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study - BioSpace
Fri, 07 Aug 2026 06:39:00 GMTVistagen’s Fasedienol Phase 2 Data Due August 2026 for Social Anxiety - The Clinical Trial Vanguard
Thu, 06 Aug 2026 21:55:50 GMTVistaGen reports Phase 2 fasedienol trial topline results - TipRanks
Thu, 06 Aug 2026 15:59:51 GMTVistagen (VTGN) Reports Phase 2 Social Anxiety Study Results Ami - GuruFocus
Thu, 06 Aug 2026 14:32:35 GMTDouble shot of Vistagen’s anxiety nasal spray misses in ph. 2 - Fierce Biotech

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Vistagen.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.